An alteration was observed by Olsson et al. in the ratio of estrogen receptor beta (ERβ) to CYP7B1 mRNA in the tumor regions, suggesting a potential disruption in estrogen signaling within prostate cancer cells [9]. Here, CYP7B1 is linked to neoplasm.